An Internet-Based Education Program for Care Partners of People Living With Dementia

October 17, 2023 updated by: McMaster University

An Internet-Based Education Program for Care Partners of People Living With Dementia (iGeriCare): A Pilot Randomized Controlled Trial

With the aging population, the prevalence of dementia is increasing dramatically. People living with dementia are highly dependent on family care partners, who may have little knowledge of the disorder. National and provincial guidelines have all highlighted the importance of online resources to improve care partner education; however, very few have been widely implemented or rigorously studied.

The investigators have developed the award-winning dementia education platform to complement traditional patient and family educational approaches. It allows free access to multimedia e-learning lessons, live expert webinars, and email-based content that care partners can access any time, anywhere.

In a pilot randomized controlled trial (RCT), the investigators propose to study 1) the feasibility and care partner acceptance of the intervention and some of the study methods, and 2) the impact of the intervention on care partner self-efficacy, knowledge, and sense of burden.

This initiative has the potential to improve the quality, cost effectiveness, and efficiency of dementia care. The intervention could be easily scaled and spread both provincially and nationally to complement other dementia education methods, at a time when the prevalence of dementia is increasing and access to high quality internet-based interventions is essential.

Study Overview

Study Type

Interventional

Enrollment (Actual)

125

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Hamilton, Ontario, Canada, L8S 4L8
        • McMaster University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. they are a family and/or friend care partner of a person living with dementia,
  2. they reside in Canada,
  3. they are 18 years of age and over,
  4. they have a good command of the English language,
  5. they have access to email and internet,
  6. they are comfortable using email and internet,
  7. they have the ability to grant online informed consent, and
  8. they complete online baseline assessments.

Exclusion Criteria:

  1. they are a not family and/or friend care partner of a person living with dementia,
  2. they do not reside in Canada,
  3. they are not 18 years of age and over,
  4. they do not have a good command of the English language,
  5. they do not have access to email and internet,
  6. they are not comfortable using email and internet,
  7. they do not have the ability to grant online informed consent, and
  8. they do not complete online baseline assessments.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Education Intervention

Participants in the intervention group will be provided e-learning about dementia and promoting brain health, consisting of the following components:

  1. Ten selected multimedia e-learning lessons;
  2. A series of 16 'micro-learning' emails (2 emails/week) with small segments of content to reinforce the material from the lessons.

Participants will have 8-weeks to complete the intervention. The total time to complete is approximately 5-6 hours.

Active Comparator: Education Control

Participants in the control group will be provided e-learning about dementia and promoting brain health, consisting of the following components:

  1. One selected multimedia e-learning lesson;
  2. A series of 16 'micro-learning' emails (2 emails/week) with small segments of content to reinforce the material from the lessons.

Participants will have 8-weeks to complete. The total time to complete is approximately 1-2 hours.

Note: All participants will receive access to all e-learning at the conclusion of the study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intervention adherence (time spent)
Time Frame: 8 weeks
Lesson completed data and email open rates will be collected and saved to quantify the time(s) spent on intervention activities.
8 weeks
Participant satisfaction
Time Frame: 8 weeks
A custom satisfaction questionnaire data adapted from the Information Assessment Method For All (IAM4all) will be collected and saved to assess satisfaction with the intervention.
8 weeks
Participant satisfaction
Time Frame: 8 weeks
A custom implementation oral interview questionnaire adapted from The Consolidated Framework for Implementation Research (CFIR) will be collected and saved to assess implementation of the intervention.
8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment rates
Time Frame: 8 weeks
Participant recruitment numbers will be collected and saved to quantify the number of interested participants.
8 weeks
Attrition rates
Time Frame: 8 weeks
Participant attrition rates will be collected and saved to quantify the number of study dropouts vs completions
8 weeks
Change from baseline in the Revised Scale for Caregiving Self-Efficacy (RSCSE) at 8 weeks.
Time Frame: 0, 8 weeks
Self-efficacy will be measured through the Revised Scale for Caregiving Self-Efficacy (RSCSE) (reliability α = >.80). The RSCSE contains 15 items within 3 subscales (self-efficacy for obtaining respite, responding to disruptive patient behaviours, and controlling upsetting thoughts about caregiving). Higher scores indicate a higher level of self-efficacy.
0, 8 weeks
Change from baseline in the Dementia Knowledge Assessment Scale (DKAS) at 8 weeks.
Time Frame: 0, 8 weeks
Knowledge will be measured through the Dementia Knowledge Assessment Scale (DKAS) (reliability α = .85; ωh = .87; overall scale). The DKAS consists of 25 items on different aspects of dementia that could be answered with 'True,' 'Probably True,' 'False, 'Probably False,' or 'I don't know.' Higher scores indicate a higher level of dementia knowledge.
0, 8 weeks
Change from baseline in the Zarit Burden Interview (ZBI) at 8 weeks.
Time Frame: 0, 8 weeks
Burden will be measured through the Zarit Burden Interview (ZBI) (reliability α = .92). The ZBI contains 22 items. Each item on the interview is a statement which the caregiver is asked to endorse using a 5-point scale. Response options range from 0 (Never) to 4 (Nearly Always). Higher scores indicate a higher level of burden.
0, 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 6, 2022

Primary Completion (Actual)

September 5, 2023

Study Completion (Actual)

September 5, 2023

Study Registration Dates

First Submitted

October 15, 2021

First Submitted That Met QC Criteria

October 29, 2021

First Posted (Actual)

November 9, 2021

Study Record Updates

Last Update Posted (Actual)

October 19, 2023

Last Update Submitted That Met QC Criteria

October 17, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dementia

Clinical Trials on Education Intervention

3
Subscribe